Ir.ardelyx.com

Ardelyx Announces $20 Million Financing Agreement with …

WebHealthCare Royalty Partners funding supports the ongoing launch of IBSRELA ® in the United States in exchange for future hyperphosphatemia royalty …

Actived: 7 days ago

URL: https://ir.ardelyx.com/news-releases/news-release-details/ardelyx-announces-20-million-financing-agreement-healthcare

Ardelyx Announces Acceptance of New Drug Application for …

WebAcceptance of NDA Submission triggers as $2 million milestone payment to Ardelyx by Fosun Pharma. WALTHAM, Mass., July 13, 2023 (GLOBE NEWSWIRE) -- …

Category:  Health Go Health

Tenapanor for Hyperphosphatemia Approved in Japan

WebApproval announced by Kyowa Kirin, Ardelyx Collaboration Partner. Ardelyx to receive $30 million from Kyowa Kirin in milestone and license amendment payments …

Category:  Health Go Health

Ardelyx to Participate at the Cowen 43rd Annual Health Care …

WebWALTHAM, Mass., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and …

Category:  Health Go Health

Ardelyx Reports Successful Phase 3 T3MPO-1 Trial of Tenapanor in

WebThe T3MPO-1 trial achieved statistical significance for the primary endpoint and seven of eight secondary endpoints. The primary endpoint, the combined responder …

Category:  Health Go Health

Press Release Details

WebFREMONT, Calif., Sept. 12, 2019 /PRNewswire/ -- Ardelyx, Inc. (NASDAQ: ARDX), a specialized biopharmaceutical company focused on developing innovative first-in-class …

Category:  Health Go Health

Ardelyx Strengthens Management Team with Appointment of …

WebFREMONT, Calif., May 18, 2020 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a specialized biopharmaceutical company focused on developing innovative first-in-class …

Category:  Health Go Health

Ardelyx to Provide Updates on Research and Development …

WebFREMONT, Calif., July 14, 2015 /PRNewswire/ -- Ardelyx, Inc. (NASDAQ: ARDX), a clinical-stage biopharmaceutical company focused on gastrointestinal and cardio-renal diseases, …

Category:  Health Go Health

PRESS RELEASES Ardelyx, Inc.

WebApr 18, 2024. Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024. Mar 28, 2024. Ardelyx, Inc. Reports Employment Inducement Grants. Mar 25, 2024. Ardelyx …

Category:  Health Go Health

FDA Approves XPHOZAH® (tenapanor), a First-in-Class Phosphate

WebXPHOZAH has been approved to reduce serum phosphorus in adults with chronic kidney disease (CKD) on dialysis as add-on therapy in patients who have an …

Category:  Health Go Health

Ardelyx Appoints Renowned Nephrologist, Geoffrey A. Block, M.D., …

WebFREMONT, Calif., March 14, 2019 /PRNewswire/ -- Ardelyx, Inc. (NASDAQ: ARDX), today announced the appointment of Geoffrey A. Block, M.D., Vice President, Nephrology at …

Category:  Health Go Health

Ardelyx and Kyowa Kirin Amend License Agreement for Tenapanor

WebWALTHAM, Mass., April 11, 2022 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and …

Category:  Health Go Health

Ardelyx Publishes First Environmental, Social and Governance (ESG

WebReport focuses on patient access and affordability, workforce wellness and training, community involvement and sound corporate governance. WALTHAM, Mass., …

Category:  Health Go Health

Ardelyx Strengthens Executive Leadership Team with the …

Web"We are excited to have Paul join Ardelyx at a time when the Company is advancing several mid- to late-stage clinical programs for IBS-C, hyperphosphatemia …

Category:  Health Go Health

Ardelyx to Participate at the Cowen 44th Annual Health Care …

WebWALTHAM, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and …

Category:  Health Go Health

Cowen 44th Annual Health Care Conference Ardelyx, Inc.

WebGreater Boston 400 Fifth Avenue, Suite 210 Waltham, MA 02451 Bay Area 34175 Ardenwood Boulevard Fremont, CA 94555

Category:  Health Go Health

Ardelyx Announces XPHOZAH® (tenapanor) Now Available in the …

WebWALTHAM, Mass., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and …

Category:  Health Go Health

Ardelyx Reports Fourth Quarter and Full Year 2022 Financial …

WebContinued successful launch of IBSRELA, ending FY 2022 with $15.6 million in net product sales. Resubmission of XPHOZAH New Drug Application expected in …

Category:  Health Go Health